Artificial Intelligence In Drug Repurposing Global Market Report 2026

Description

Artificial intelligence in drug repurposing refers to the use of artificial intelligence techniques to identify new medical applications for existing drugs. It applies advanced data analytics, machine learning, and predictive modeling to examine biological, chemical, and clinical data for potential therapeutic matches. This approach speeds up drug discovery, lowers research costs, and improves the efficiency of pharmaceutical development.

The primary components of artificial intelligence in drug repurposing include software and platforms and services. Software and platforms consist of digital tools and environments that facilitate the development, deployment, and utilization of applications and services. It employs various technologies such as machine learning or deep learning, natural language processing, knowledge graphs and network-based artificial intelligence, generative artificial intelligence and large language models, and computer vision. The different deployment modes include cloud-based and on-premises. Various therapeutic areas include oncology, neurology, cardiovascular diseases, infectious diseases, immunology, metabolic disorders, and rare diseases, and they serve several end-users, including pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes, healthcare providers, and others.

Tariffs are influencing the artificial intelligence in drug repurposing market by increasing the cost of imported high-performance computing infrastructure, specialized accelerators, and laboratory data acquisition equipment used in AI-driven discovery workflows. Pharmaceutical and biotechnology companies in North America and Europe are most affected due to reliance on global supply chains for compute and research hardware, which can raise project costs and extend timelines. Contract research organizations may also face higher operational expenses when scaling AI platforms. However, tariffs are encouraging regional investment in local data centers, cloud-based research environments, and more efficient AI models that reduce compute requirements while maintaining discovery accuracy.

The artificial intelligence in drug repurposing market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in drug repurposing market statistics, including artificial intelligence in drug repurposing industry global market size, regional shares, competitors with a artificial intelligence in drug repurposing market share, detailed artificial intelligence in drug repurposing market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in drug repurposing industry. This artificial intelligence in drug repurposing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in drug repurposing market size has grown exponentially in recent years. It will grow from $1.05 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 20.3%. The growth in the historic period can be attributed to rising r&d costs in pharmaceutical development, availability of public biomedical datasets, growth of computational biology tools, need to accelerate time to market for therapies, increasing collaboration between pharma and AI startups.

The artificial intelligence in drug repurposing market size is expected to see exponential growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 20.1%. The growth in the forecast period can be attributed to growth of AI-assisted clinical decision support, increasing use of generative AI for molecule insights, need for faster repurposing during health crises, expansion of real-world evidence analytics, rising investments in precision medicine pipelines. Major trends in the forecast period include AI-driven drug-target matching from multi-omics data, repurposing pipelines using knowledge graph discovery, virtual screening and trial simulation acceleration, federated learning for cross-institution research, explainable AI for clinical repurposing decisions.

The increasing demand for precision medicine is expected to drive the growth of the artificial intelligence in drug repurposing market in the coming years. Precision medicine is a healthcare approach that customizes disease prevention and treatment based on an individual's unique genes, behaviors, and environment. The growing preference for personalized treatments is fueling the expansion of precision medicine, as patients and healthcare providers increasingly seek therapies tailored to individual genetic and lifestyle profiles for improved effectiveness and fewer side effects. Artificial intelligence-driven drug repurposing supports precision medicine by identifying existing drugs that match an individual's genetic or molecular characteristics, enabling more accurate and personalized treatment solutions. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based nonprofit organization, the Food and Drug Administration approved sixteen personalized therapies targeting rare diseases in 2023, a significant increase compared to six approvals in 2022. Therefore, the rising demand for precision medicine is propelling the growth of the artificial intelligence in drug repurposing market.

Key companies operating in the artificial intelligence in drug repurposing market are concentrating on integrating advanced technologies in drug repositioning, such as computational drug repositioning systems, which systematically identify new therapeutic indications for existing drugs using data-driven analysis of literature and biological information. A computational drug repositioning system refers to a technology-based platform that employs artificial intelligence, machine learning, and data mining to systematically analyze existing drugs, compounds, and biological data. For instance, in November 2023, Tempus, a United States-based provider of artificial intelligence-based precision medicine solutions, announced a multi-year strategic collaboration with Recursion, a United States-based clinical-stage biotechnology company, valued at up to one hundred sixty million dollars over five years. The collaboration grants Recursion access to Tempus' extensive library of de-identified, multimodal oncology data to support biomarker-driven therapeutic development. By leveraging Tempus' large-scale patient datasets alongside Recursion's artificial intelligence-enabled discovery capabilities, the partnership strengthens oncology drug repurposing initiatives, demonstrating how advanced computational platforms combined with real-world clinical data can accelerate the identification of new treatment opportunities.

In January 2024, Cosmos Health Incorporated, a United States-based diversified healthcare company, acquired Cloudscreen for an undisclosed amount. Through this acquisition, Cosmos Health aims to strengthen drug repurposing capabilities and speed up the identification of new therapeutic applications for existing drugs. Cloudscreen is a United States-based company specializing in artificial intelligence-powered drug repurposing solutions.

Major companies operating in the artificial intelligence in drug repurposing market are IBM Corporation, Evogene Ltd., Ginkgo Bioworks Holdings Inc., BioAge Labs Inc., Insilico Medicine Inc., BostonGene Corporation, ISOMORPHIC LABS, Recursion Pharmaceuticals Inc., Deep Genomics Inc., Healx Ltd., Owkin Inc., BullFrog AI Holdings Inc., Aicura Medical GmbH, Kantify, Ignota Labs Ltd., OrphAI Therapeutics, Nabla Bio, Atomwise Inc., BioXcel Therapeutics Inc., Graph AI.

North America was the largest region in the artificial intelligence in drug repurposing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in drug repurposing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence in drug repurposing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence in drug repurposing market includes revenues earned by entities by providing services such as predictive modelling, target identification, drug-disease interaction analysis, virtual screening, and clinical data mining. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Drug Repurposing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence in drug repurposing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in drug repurposing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in drug repurposing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Component: Software And Platforms; Services
2) By Technology: Machine Learning Or Deep Learning; Natural Language Processing (NLP); Knowledge Graphs And Network-Based Artificial Intelligence; Generative Artificial Intelligence And Large Language Models (LLMs); Computer Vision
3) By Deployment: Cloud-Based; On-Premises
4) By Therapeutic Area: Oncology; Neurology; Cardiovascular Diseases; Infectious Diseases; Immunology; Metabolic Disorders; Rare Diseases
5) By End-User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Academic And Research Institutes; Healthcare Providers; Other End-Users
Subsegments:
1) By Software And Platforms: Predictive Analytics Tools; Machine Learning Frameworks; Data Integration Systems; Drug Discovery Platforms; Clinical Trial Simulation Tools
2) By Services: Consulting Services; Data Management Services; Model Training And Optimization Services; Implementation And Integration Services; Support And Maintenance Services
Companies Mentioned: IBM Corporation; Evogene Ltd.; Ginkgo Bioworks Holdings Inc.; BioAge Labs Inc.; Insilico Medicine Inc.; BostonGene Corporation; ISOMORPHIC LABS; Recursion Pharmaceuticals Inc.; Deep Genomics Inc.; Healx Ltd.; Owkin Inc.; BullFrog AI Holdings Inc.; Aicura Medical GmbH; Kantify; Ignota Labs Ltd.; OrphAI Therapeutics; Nabla Bio; Atomwise Inc.; BioXcel Therapeutics Inc.; Graph AI.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: IT4MAIDR02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence In Drug Repurposing Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Artificial Intelligence In Drug Repurposing Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence In Drug Repurposing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Artificial Intelligence In Drug Repurposing Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Artificial Intelligence & Autonomous Intelligence
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Fintech, Blockchain, Regtech & Digital Finance
- 4.1.5 Sustainability, Climate Tech & Circular Economy
4.2. Major Trends
- 4.2.1 AI-Driven Drug-Target Matching From Multi-Omics Data
- 4.2.2 Repurposing Pipelines Using Knowledge Graph Discovery
- 4.2.3 Virtual Screening And Trial Simulation Acceleration
- 4.2.4 Federated Learning For Cross-Institution Research
- 4.2.5 Explainable AI For Clinical Repurposing Decisions

5. Artificial Intelligence In Drug Repurposing Market Analysis Of End Use Industries

5.1 Pharmaceutical And Biotechnology Companies
5.2 Contract Research Organizations (Cros)
5.3 Academic And Research Institutes
5.4 Healthcare Providers
5.5 Government Research Agencies

6. Artificial Intelligence In Drug Repurposing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence In Drug Repurposing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Artificial Intelligence In Drug Repurposing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Artificial Intelligence In Drug Repurposing Market Size, Comparisons And Growth Rate Analysis
7.3. Global Artificial Intelligence In Drug Repurposing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Artificial Intelligence In Drug Repurposing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence In Drug Repurposing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence In Drug Repurposing Market Segmentation

9.1. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Software And Platforms, Services
9.2. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Machine Learning Or Deep Learning, Natural Language Processing (NLP), Knowledge Graphs And Network-Based Artificial Intelligence, Generative Artificial Intelligence And Large Language Models (LLMs), Computer Vision
9.3. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cloud-Based, On-Premises
9.4. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases
9.5. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Healthcare Providers, Other End-Users
9.6. Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Software And Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Predictive Analytics Tools, Machine Learning Frameworks, Data Integration Systems, Drug Discovery Platforms, Clinical Trial Simulation Tools
9.7. Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Consulting Services, Data Management Services, Model Training And Optimization Services, Implementation And Integration Services, Support And Maintenance Services

10. Artificial Intelligence In Drug Repurposing Market, Industry Metrics By Country

10.1. Global Artificial Intelligence In Drug Repurposing Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
10.2. Global Artificial Intelligence In Drug Repurposing Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Artificial Intelligence In Drug Repurposing Market Regional And Country Analysis

11.1. Global Artificial Intelligence In Drug Repurposing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11.2. Global Artificial Intelligence In Drug Repurposing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Artificial Intelligence In Drug Repurposing Market

12.1. Asia-Pacific Artificial Intelligence In Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Artificial Intelligence In Drug Repurposing Market

13.1. China Artificial Intelligence In Drug Repurposing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
13.2. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Artificial Intelligence In Drug Repurposing Market

14.1. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Artificial Intelligence In Drug Repurposing Market

15.1. Japan Artificial Intelligence In Drug Repurposing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
15.2. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Artificial Intelligence In Drug Repurposing Market

16.1. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Artificial Intelligence In Drug Repurposing Market

17.1. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Artificial Intelligence In Drug Repurposing Market

18.1. South Korea Artificial Intelligence In Drug Repurposing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Artificial Intelligence In Drug Repurposing Market

19.1. Taiwan Artificial Intelligence In Drug Repurposing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. Taiwan Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Artificial Intelligence In Drug Repurposing Market

20.1. South East Asia Artificial Intelligence In Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. South East Asia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Artificial Intelligence In Drug Repurposing Market

21.1. Western Europe Artificial Intelligence In Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
21.2. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Artificial Intelligence In Drug Repurposing Market

22.1. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Artificial Intelligence In Drug Repurposing Market

23.1. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Artificial Intelligence In Drug Repurposing Market

24.1. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Artificial Intelligence In Drug Repurposing Market

25.1. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Artificial Intelligence In Drug Repurposing Market

26.1. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Artificial Intelligence In Drug Repurposing Market

27.1. Eastern Europe Artificial Intelligence In Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
27.2. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Artificial Intelligence In Drug Repurposing Market

28.1. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Artificial Intelligence In Drug Repurposing Market

29.1. North America Artificial Intelligence In Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Artificial Intelligence In Drug Repurposing Market

30.1. USA Artificial Intelligence In Drug Repurposing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Artificial Intelligence In Drug Repurposing Market

31.1. Canada Artificial Intelligence In Drug Repurposing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Artificial Intelligence In Drug Repurposing Market

32.1. South America Artificial Intelligence In Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
32.2. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Artificial Intelligence In Drug Repurposing Market

33.1. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Artificial Intelligence In Drug Repurposing Market

34.1. Middle East Artificial Intelligence In Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Artificial Intelligence In Drug Repurposing Market

35.1. Africa Artificial Intelligence In Drug Repurposing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
35.2. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Artificial Intelligence In Drug Repurposing Market Regulatory and Investment Landscape

37. Artificial Intelligence In Drug Repurposing Market Competitive Landscape And Company Profiles

37.1. Artificial Intelligence In Drug Repurposing Market Competitive Landscape And Market Share 2024
- 37.1.1. Top 10 Companies (Ranked by revenue/share)
37.2. Artificial Intelligence In Drug Repurposing Market - Company Scoring Matrix
- 37.2.1. Market Revenues
- 37.2.2. Product Innovation Score
- 37.2.3. Brand Recognition
37.3. Artificial Intelligence In Drug Repurposing Market Company Profiles
- 37.3.1. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- 37.3.2. Evogene Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 37.3.3. Ginkgo Bioworks Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 37.3.4. BioAge Labs Inc. Overview, Products and Services, Strategy and Financial Analysis
- 37.3.5. Insilico Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis

38. Artificial Intelligence In Drug Repurposing Market Other Major And Innovative Companies

BostonGene Corporation, ISOMORPHIC LABS, Recursion Pharmaceuticals Inc., Deep Genomics Inc., Healx Ltd., Owkin Inc., BullFrog AI Holdings Inc., Aicura Medical GmbH, Kantify, Ignota Labs Ltd., OrphAI Therapeutics, Nabla Bio, Atomwise Inc., BioXcel Therapeutics Inc., Graph AI

39. Global Artificial Intelligence In Drug Repurposing Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The Artificial Intelligence In Drug Repurposing Market

41. Artificial Intelligence In Drug Repurposing Market High Potential Countries, Segments and Strategies

41.1. Artificial Intelligence In Drug Repurposing Market In 2030 - Countries Offering Most New Opportunities
41.2. Artificial Intelligence In Drug Repurposing Market In 2030 - Segments Offering Most New Opportunities
41.3. Artificial Intelligence In Drug Repurposing Market In 2030 - Growth Strategies
- 41.3.1. Market Trend Based Strategies
- 41.3.2. Competitor Strategies

42. Appendix

42.1. Abbreviations
42.2. Currencies
42.3. Historic And Forecast Inflation Rates
42.4. Research Inquiries
42.5. The Business Research Company
42.6. Copyright And Disclaimer